Lumeva · MIG · Spain · Primary care physician · captured by Luis Ortega on 01 Jun 2026 · reviewed by Dr. Sophie Laurent on 03 Jun 2026
Verbatim as captured; never edited
Primary care physician at Hospital Clínic Barcelona raised drug interactions during a scientific exchange. They requested supporting literature and a follow-up discussion.
Human-approved by Dr. Sophie Laurent on 03 Jun 2026
Drug interactions: interest in collaboration reported by primary care physician (ES).
helixor-private-llm-2026.05 · generated 01 Jun 2026, 10:00 UTC
AI summary
Drug interactions raised by primary care physician; suggest routing to Medical Affairs.
Source spans used by the model
Primary care physician at Hospital Clínic Barcelona raised drug interactions during a scientific exchange. They requested supporting literature and a follow-up discussion.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Health economics | Clinical practice |
| Function | Medical Affairs | Medical Affairs |
| Priority | High | High |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 4 | 20% | 16.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 5 | 15% | 15.0 |
| Novelty | 3 | 10% | 6.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 3 | 5% | 3.0 |
| Breadth of occurrence | 2 | 5% | 2.0 |
| Total | High 70 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
01 Jun 2026 · Dr. Benedikt Rossi, Hospital Clínic Barcelona · MSL Luis Ortega
Insight
Reviewed 03 Jun 2026 by Dr. Sophie Laurent
Action
Initiative
Decision
Outcome
Closure
Incorporated into evidence-generation plan.